Gelpoint V-Path
Payments companies reported to CMS as associated with Gelpoint V-Path. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gelpoint V-Path, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gelpoint V-Path
These are the largest totals companies reported as associated with Gelpoint V-Path. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Grover May | Johnson City, TN | Obstetrics & Gynecology | $309,249.98 |
| Veronica Lerner | New York, NY | Obstetrics & Gynecology | $295,032.50 |
| Jerry Matkins | Charlotte, NC | Obstetrics & Gynecology | $282,206.42 |
| Howard Salvay | Santa Cruz, CA | Obstetrics & Gynecology | $259,164.65 |
| Caren Reaves | Flower Mound, TX | Obstetrics & Gynecology | $193,480.31 |
| Brandi Hardin | Spartanburg, SC | Obstetrics | $166,017.76 |
| Dani Zoorob | Shreveport, LA | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $148,161.75 |
| Robin Matthews | Clyde, NC | Obstetrics & Gynecology | $138,749.24 |
| Henry Garza III | San Antonio, TX | Obstetrics & Gynecology | $104,947.40 |
| Daniel Gomez | Tampa, FL | Obstetrics & Gynecology | $96,382.56 |
Prescribed Gelpoint V-Path?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.